ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00309062
Recruitment Status : Completed
First Posted : March 31, 2006
Last Update Posted : March 11, 2013
Sponsor:
Information provided by (Responsible Party):
Allergopharma GmbH & Co. KG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : June 2009